Literature DB >> 27879017

Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release.

Tetsuya Kadonosono1, Wanaporn Yimchuen1, Takuya Tsubaki1, Tadashi Shiozawa1, Yasuhiro Suzuki2, Takahiro Kuchimaru1, Yasufumi Sato2, Shinae Kizaka-Kondoh1.   

Abstract

Vasohibins (VASH1 and VASH2) are recently identified regulators of angiogenesis and cancer cell functions. They are secreted proteins without any classical secretion signal sequences, and are thought to be secreted instead via an unconventional protein secretion (UPS) pathway in a small vasohibin-binding protein (SVBP)-dependent manner. However, the precise mechanism of SVBP-dependent UPS is poorly understood. In this study, we identified a novel UPS regulatory system in which essential domain architecture (VASH-PS) of VASHs, comprising regions VASH191-180 and VASH280-169 , regulate the cytosolic punctate structure formation in the absence of SVBP. We also demonstrate that SVBP form a complex with VASH1 through the VASH1274-282 (SIa), VASH1139-144 (SIb), and VASH1133-137 (SIc), leading to the dispersion in the cytosol and extracellular release of VASH1. The amino acid sequences of VASH-SIa and VASH-PS, containing SIb and SIc, are highly conserved among VASH family members in vertebrates, suggesting that SVBP-dependent UPS may be common within the VASH family. This novel UPS regulatory system may open up new avenues for understanding fundamental protein secretion in vertebrates.
© 2016 The Protein Society.

Entities:  

Keywords:  molecular chaperon; punctate structure formation; unconventional protein secretion; vasohibins

Mesh:

Substances:

Year:  2017        PMID: 27879017      PMCID: PMC5326560          DOI: 10.1002/pro.3089

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  42 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

Review 2.  Unconventional protein secretion.

Authors:  Yu Ding; Juan Wang; Junqi Wang; York-Dieter Stierhof; David G Robinson; Liwen Jiang
Journal:  Trends Plant Sci       Date:  2012-07-09       Impact factor: 18.313

Review 3.  Pathways of unconventional protein secretion.

Authors:  Walter Nickel
Journal:  Curr Opin Biotechnol       Date:  2010-07-14       Impact factor: 9.740

4.  Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells.

Authors:  Kazue Shimizu; Kazuhide Watanabe; Hiroshi Yamashita; Mayumi Abe; Hironobu Yoshimatsu; Hideki Ohta; Hikaru Sonoda; Yasufumi Sato
Journal:  Biochem Biophys Res Commun       Date:  2005-02-18       Impact factor: 3.575

5.  Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin.

Authors:  Hikaru Sonoda; Hideki Ohta; Kazuhide Watanabe; Hiroshi Yamashita; Hiroshi Kimura; Yasufumi Sato
Journal:  Biochem Biophys Res Commun       Date:  2006-02-13       Impact factor: 3.575

6.  Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme.

Authors:  Konstantin Glebov; Sebastian Schütze; Jochen Walter
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

7.  Distinctive role of vasohibin-1A and its splicing variant vasohibin-1B in tumor angiogenesis.

Authors:  S Horie; Y Suzuki; M Kobayashi; T Kadonosono; S Kondoh; T Kodama; Y Sato
Journal:  Cancer Gene Ther       Date:  2016-04-15       Impact factor: 5.987

8.  Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.

Authors:  Takumi Shibuya; Kazuhide Watanabe; Hiroshi Yamashita; Kazue Shimizu; Hiroki Miyashita; Mayumi Abe; Takuya Moriya; Hideki Ohta; Hikaru Sonoda; Tooru Shimosegawa; Koichi Tabayashi; Yasufumi Sato
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-09       Impact factor: 8.311

9.  Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins.

Authors:  Brian R McNaughton; James J Cronican; David B Thompson; David R Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

10.  Improving FRET dynamic range with bright green and red fluorescent proteins.

Authors:  Amy J Lam; François St-Pierre; Yiyang Gong; Jesse D Marshall; Paula J Cranfill; Michelle A Baird; Michael R McKeown; Jörg Wiedenmann; Michael W Davidson; Mark J Schnitzer; Roger Y Tsien; Michael Z Lin
Journal:  Nat Methods       Date:  2012-09-09       Impact factor: 28.547

View more
  5 in total

1.  Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.

Authors:  Rie Iida-Norita; Minaho Kawamura; Yasuhiro Suzuki; Shin Hamada; Atsushi Masamune; Toru Furukawa; Yasufumi Sato
Journal:  Cancer Sci       Date:  2019-06-18       Impact factor: 6.716

Review 2.  The roles of vasohibin and its family members: Beyond angiogenesis modulators.

Authors:  Hua Du; Jing Zhao; Ling Hai; Jing Wu; Hua Yi; Yonghong Shi
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

3.  Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.

Authors:  Yasuhiro Suzuki; Shuji Kitahara; Takuya Suematsu; Masanobu Oshima; Yasufumi Sato
Journal:  Cancer Sci       Date:  2017-10-21       Impact factor: 6.716

4.  Design Strategy to Create Antibody Mimetics Harbouring Immobilised Complementarity Determining Region Peptides for Practical Use.

Authors:  Tetsuya Kadonosono; Wanaporn Yimchuen; Yumi Ota; Kyra See; Tadaomi Furuta; Tadashi Shiozawa; Maika Kitazawa; Yu Goto; Akash Patil; Takahiro Kuchimaru; Shinae Kizaka-Kondoh
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

5.  The crystal structure of the tetrameric human vasohibin-1-SVBP complex reveals a variable arm region within the structural core.

Authors:  Akihito Ikeda; Seia Urata; Tadashi Ando; Yasuhiro Suzuki; Yasufumi Sato; Tatsuya Nishino
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-09-16       Impact factor: 7.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.